Menu
Equities By Region Manufacturing Services UK

Smiths share price underperforms as JPMorgan points to limited upside

Share this article!

Shares in Smiths Group (LON:SMIN) have fallen into the red in today’s session, as analysts at JPMorgan Cazenove trimmed their stance on the company, pointing to limited upside. The move follows the FTSE 100 group’s full-year results last week when the company reported a drop in full-year revenue and profit, pressured by downbeat performance at its Medical unit.

As of 13:29 BST, Smith’s share price had given up 1.09 percent to 1,504.00p. The stock is underperforming the broader UK market, with the benchmark FTSE 100 index currently standing 0.24 percent lower at 7,472.28 points.

JPMorgan trims stance on Smiths

JPMorgan Cazenove trimmed its rating on Smiths from ‘overweight’ to ‘neutral’ today, also lowering its price target on the shares from 1,690p to 1,660p. Proactive Investors quoted the analysts as saying that that an improvement in the second half of the year had returned the FTSE 100 group to underlying revenue growth of two percent for the full year.

“As expected there was a sharp bounce in organic growth in the Detection division and the pace of organic growth accelerated in most other divisions,” the broker pointed out, noting that the integration of Morpho Detection, which Smiths acquired during the year, “had progressed smoothly resulting in the cost savings being delivered more swiftly than anticipated”.

The newswire further quoted the analysts as noting that they expect “2019 to be a year of steady progress in the operating performance of the group”.

Analyst ratings update

As of September 21, the consensus forecast amongst 17 polled investment analysts covering Smiths Group for the Financial Times has it that the company will outperform the market. According to MarketBeat, the blue-chip engineering group currently has a consensus ‘buy’ rating and an average price target of 1,715.91p.

As of 13:47 BST, Monday, 24 September, Smiths Group plc share price is 1,504.00p.

Add Comment

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.